CLINICAL_TRIALS
trial_result
· 2011-12-29
Clinical Trial Update: Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia [Phase 3]
Summary
Phase 3 trial assessing idebenone for Friedreich's ataxia completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Santhera Pharmaceuticals | Conditions: Friedreich's Ataxia | Phase 3 | Status: COMPLETED | Results posted: 2011-12-29